Literature DB >> 16306552

Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects.

Auni Juutilainen1, Seppo Lehto, Tapani Rönnemaa, Kalevi Pyörälä, Markku Laakso.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the hypothesis that coronary heart disease (CHD) mortality in diabetic subjects without prior evidence of CHD is equal to that in nondiabetic subjects with prior myocardial infarction or any prior evidence of CHD. RESEARCH DESIGN AND METHODS: During an 18-year follow-up total, cardiovascular disease (CVD) and CHD deaths were registered in a Finnish population-based study of 1,373 nondiabetic and 1,059 diabetic subjects.
RESULTS: Adjusted multivariate Cox hazard models indicated that diabetic subjects without prior myocardial infarction, compared with nondiabetic subjects with prior myocardial infarction, had a hazard ratio (HR) of 0.9 (95% CI 0.6-1.5) for the risk of CHD death. The corresponding HR was 0.9 (0.5-1.4) in men and 1.9 (0.6 -6.1) in women. Diabetic subjects without any prior evidence of CHD (myocardial infarction or ischemic electrocardiogram [ECG] changes or angina pectoris), compared with nondiabetic subjects with prior evidence of CHD, had an HR of 1.9 (1.4-2.6) for CHD death (men 1.5 [1.0-2.2]; women 3.5 [1.8-6.8]). The results for CVD and total mortality were quite similar to those for CHD mortality.
CONCLUSIONS: Diabetes without prior myocardial infarction and prior myocardial infarction without diabetes indicate similar risk for CHD death in men and women. However, diabetes without any prior evidence of CHD (myocardial infarction or angina pectoris or ischemic ECG changes) indicates a higher risk than prior evidence of CHD in nondiabetic subjects, especially in women.

Entities:  

Mesh:

Year:  2005        PMID: 16306552     DOI: 10.2337/diacare.28.12.2901

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  120 in total

1.  The Interdependence of Blood Pressure and Glucose in Vietnam.

Authors:  Tran Thi Thu Nga; Christopher Leigh Blizzard; Luong Ngoc Khue; Truong Le Van Ngoc; Tran Quoc Bao; Petr Otahal; Mark R Nelson; Costan G Magnussen; Bui Van Tan; Velandai Srikanth; Au Bich Thuy; Ha Thai Son; Phung Ngoc Hai; Tran Hoang Mai; Michele Callisaya; Seana Gall
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-01-16

2.  Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.

Authors:  N Matikainen; S Mänttäri; A Schweizer; A Ulvestad; D Mills; B E Dunning; J E Foley; M-R Taskinen
Journal:  Diabetologia       Date:  2006-07-01       Impact factor: 10.122

Review 3.  Cardiovascular risk in children and adolescents with type 2 diabetes mellitus.

Authors:  Christopher Prendergast; Samuel S Gidding
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

Review 4.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

5.  Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians.

Authors:  Michel P Hermans; Jean-Charles Fruchart
Journal:  Ther Adv Chronic Dis       Date:  2011-09       Impact factor: 5.091

6.  The effect of prevalent cardiovascular conditions on the association between alcohol consumption and mortality among older Mexican American men.

Authors:  Majd AlGhatrif; Kyriakos S Markides; Yong-fang Kuo; Laura A Ray; Alison A Moore
Journal:  Ethn Dis       Date:  2013       Impact factor: 1.847

7.  Endothelial Dysfunction: An Early Cardiovascular Risk Marker in Asymptomatic Obese Individuals with Prediabetes.

Authors:  Alok K Gupta; Eric Ravussin; Darcy L Johannsen; April J Stull; William T Cefalu; William D Johnson
Journal:  Br J Med Med Res       Date:  2012-05-30

8.  Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.

Authors:  K Eeg-Olofsson; J Cederholm; P M Nilsson; B Zethelius; L Nunez; S Gudbjörnsdóttir; B Eliasson
Journal:  Diabetologia       Date:  2008-11-05       Impact factor: 10.122

9.  Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial.

Authors:  Matti Uusitupa; Markku Peltonen; Jaana Lindström; Sirkka Aunola; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Timo T Valle; Johan G Eriksson; Jaakko Tuomilehto
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

Review 10.  Cardiovascular risk assessment scores for people with diabetes: a systematic review.

Authors:  P Chamnan; R K Simmons; S J Sharp; S J Griffin; N J Wareham
Journal:  Diabetologia       Date:  2009-07-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.